Evidence map›Paper›PMID 22027566›Full record

ReviewJournal of pediatric gastroenterology and nutrition2012

Brain-gut axis: from basic understanding to treatment of IBS and related disorders.

Michael Camilleri, Carlo Di Lorenzo

Abstract readReview
In one paragraph

Review in Journal of pediatric gastroenterology and nutrition, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Brain-Gut Axis: Clinical Implications.Gastroenterology clinics of North America · 2018
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Observational
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Michael CamilleriClinical Enteric Neuroscience Translational and Epidemiological Research, College of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA. camilleri.michael@mayo.edu
Carlo Di Lorenzo
Mayo Clinic · USNationwide Children's Hospital · US

Funding

Bile Acids, Genetic Control and Colonic Function in Irritable Bowel SyndromeR01DK092179 · NIDDK · MAYO CLINIC ROCHESTER · PI CAMILLERI, MICHAEL L. · 2011 to 2015
$1.8M
Irritable bowel syndrome-diarrhea: the role of gluten intolerance and HLA-DQ2RC1DK086182 · NIDDK · MAYO CLINIC ROCHESTER · PI CAMILLERI, MICHAEL L. · 2009 to 2010
$1.0M
Cannabinoid Mechanisms in Human Gastrointestinal Motor and Sensory FunctionsR01DK079866 · NIDDK · MAYO CLINIC ROCHESTER · PI CAMILLERI, MICHAEL L. · 2009 to 2010
$752k
NIDDK NIH HHS 1R01-DK086182NIDDK NIH HHS R01 DK079866NIDDK NIH HHS R01-DK079866NIDDK NIH HHS R01 DK092179NIDDK NIH HHS RC1 DK086182
6 · The paper itself

Abstract

The present review describes advances in understanding the mechanisms and provide an update of present and promising therapy directed at the gut or the brain in the treatment of irritable bowel syndrome (IBS). The diagnosis of IBS typically is based on identification of symptoms, such as the Rome III criteria for IBS in adults and children. The criteria are similar in children and adults. The focus of the present review is the bowel dysfunction associated with IBS.

Indexed as

AnimalsAnti-Inflammatory AgentsDisease Models, AnimalGastrointestinal TractHumansIrritable Bowel SyndromeN-MethylaspartateQuality of LifeAnti-Inflammatory AgentsN-Methylaspartate

Identifiers

PMID22027566
PMCPMC3294167
OpenAlexW102177232

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.